Last updated on March 2017

"An Open Label Trial to Evaluate the Safety of ALD403 Administered Intravenously in Patients With Chronic Migraines"


Brief description of study

"An Open Label Trial to Evaluate the Safety of ALD403 Administered Intravenously in Patients With Chronic Migraines"

Detailed Study Description

An evaluation of long term safety of repeat ALD403 doses in Chronic Migraine

Clinical Study Identifier: TX148114

Contact Investigators or Research Sites near you

Start Over

Patient Recruitment

Cedar Crosse Research Center
Chicago, IL USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.